Related Experiment Video
Updated: Jul 7, 2026

Investigating Mast Cell Secretory Granules; from Biosynthesis to Exocytosis
Published on: January 26, 2015
RabGEF1 is a negative regulator of mast cell activation and skin inflammation
See-Ying Tam1, Mindy Tsai, John N Snouwaert
1Department of Pathology, Stanford University School of Medicine, Stanford, California 94305, USA. stam@stanford.edu
Abstract:
Mast cell activation induced by aggregation of Fc epsilon RI receptors with immunoglobulin E and antigen is mediated through the activation of multiple protein kinase cascades. Here we report that the regulatory protein RabGEF1 bound to Ras and negatively regulated Ras activation and its 'downstream' effector pathways in Fc epsilon RI-dependent mast cell activation. RabGEF1-deficient mast cells showed enhanced degranulation and release of lipid mediators and cytokines in response to Fc epsilon RI aggregation. RabGEF1-deficient mice developed severe skin inflammation and had increased numbers of mast cells. Thus, RabGEF1 is a negative regulator of Fc epsilon RI-dependent mast cell activation, and a lack of RabGEF1 results in the development of skin inflammation in vivo.
Insights
RabGEF1 negatively regulates mast cell activation. Its absence leads to enhanced degranulation, mediator release, and severe skin inflammation in mice, highlighting its role in immune response.
Area of Science:
- Immunology
- Cell Biology
- Dermatology
Background:
- Mast cell activation is crucial in allergic responses and inflammation.
- Fc epsilon RI receptor aggregation triggers intracellular signaling cascades, including protein kinases.
- The precise regulators of these pathways are not fully understood.
Purpose of the Study:
- To investigate the role of the regulatory protein RabGEF1 in Fc epsilon RI-dependent mast cell activation.
- To determine the in vivo consequences of RabGEF1 deficiency in mast cell-mediated responses.
Main Methods:
- Utilized mast cells and mouse models deficient in RabGEF1.
- Assessed mast cell degranulation and mediator release.
- Analyzed skin inflammation and mast cell infiltration in vivo.
Main Results:
- RabGEF1 directly binds to Ras, negatively regulating its activation.
- RabGEF1-deficient mast cells exhibit heightened degranulation and release of inflammatory mediators.
- RabGEF1-deficient mice display severe skin inflammation with increased mast cell populations.
Conclusions:
- RabGEF1 acts as a critical negative regulator of Fc epsilon RI-mediated mast cell activation.
- Loss of RabGEF1 function promotes inflammatory responses and contributes to skin inflammation.
- Targeting RabGEF1 may offer therapeutic potential for inflammatory skin diseases.
Related Concept Videos
Rab Proteins
Rab proteins switch between a cytosolic, GDP-bound inactive state and a membrane-anchored, GTP-bound active state. By themselves, Rabs show slow rates of GDP/GTP exchange and GTP hydrolysis. Thus, Rab proteins are considered...
The Ras Gene
Ras is a superfamily...
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
MAPK Signaling Cascades
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...

